Swan-HemoCath™ Critical Care AI Platform

Advancing Patient Care in Critical Moments

HemoCath is committed to improving healthcare for critically ill patients by engineering technologies for important unmet healthcare needs

The Swan-HemoCath™ Critical Care AI Platform is a breakthrough solution addressing the largest unmet healthcare need worldwide: the management and treatment of critically ill (ICU) and heart failure (HF) patients. The innovative platform combines a minimally-invasive HemoCath pulmonary artery catheter with real-time AI-powered monitoring via the Swan AI Cloud™ (B2B AI/SaaS).

This revolutionary technology provides clinicians with continuous, accurate, and actionable hemodynamic data — enabling more effective and faster treatment decisions for ICU and HF patients — improving patient outcomes — reducing hospital stays and healthcare costs.

HemoCath™ PA Catheter

The HemoCath pulmonary artery (PA) catheter is temporarily inserted into a brachial vein on the arm and positioned into the pulmonary artery to measure PAP & CVP, the leading indicators of heart congestion, allowing early targeted therapy.

Next-gen PA catheter (4F) that is substantially less invasive, more accurate, and easier to use.

Despite the development of other monitoring tools, the PA catheter remains the Gold Standard and Standard of Care for hemodynamic monitoring in intensive care units (ICU).

PAP: pulmonary artery pressure
CVP: central venous pressure

Swan AI Cloud™

HemoCath PA catheters transmit real-time cardiovascular hemodynamic data to the Swan AI Cloud™ — continuous monitoring and optimized management of critically ill patients — enabling AI-driven optimal medication dosing for safe and effective decongestion in patients with heart failure.

The Next Generation of PA Catheters

The Swan-HemoCath™ Critical Care AI Platform is recognized by clinicians as the next generation of PA catheters, offering several key advantages over existing PA catheters:

Improved Design: Less invasive and easier to use, earning appreciation from both patients and clinicians.

Enhanced Performance: Provides precise, stable and accurate measurements over extended periods, from hours to days.

Advanced Features: Portable and MRI-compatible, enabling patient mobility and offering flexibility across diverse clinical settings.

AI-Powered Connectivity: Seamlessly integrated with the Swan AI Cloud™ (B2B AI/SaaS) for continuous monitoring and optimized care of ICU patients.

Invaluable Database: Soon, the Swan AI Cloud™ will serve as a vital resource for researchers and the heart failure industry, offering a comprehensive database of precise clinical data.

The Swan-HemoCath™ Critical Care AI Platform is recognized as the Next Generation of PA catheters.

Pictures of an actual prototype

Page updated

Report abuse